SARAH MALIK: Open Payments
NPI 1477819076 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 47 payments from 10 companies in 2025. Trend: 2023 $591 · 2024 $337 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $346 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $234 |
| ABBVIE INC. | 6 | $189 |
| Axsome Therapeutics, Inc. | 2 | $155 |
| Neurocrine BioSciences, Inc. | 2 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 2 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| Alkermes, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
Products named: CAPLYTA, VRAYLAR, Auvelity, INGREZZA, ABILIFY ASIMTUFII, UZEDY, ABILIFY MAINTENA, COBENFY.
Industry payments across MI — which companies pay providers there.
